S. Greenbloom : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (25)
Les plus populaires
Liste
- Liste
- Tableau

1

Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease

Bruce E. Sands, Eric W. Jacobson, Thomas Sylwestrowicz, Ziad Younes, Gerald Dryden, Richard Fedorak, Susan Greenbloom

Journal:

Inflammatory Bowel Diseases

Année:

2010

Langue:

english

Fichier:

PDF, 349 KB

english, 2010

2

Randomised clinical trial: the efficacy of treatment, guided by a shorter duration of response, using peginterferon alfa-2a plus ribavirin for hepatitis C virus other than genotypes 2 or 3

S. S. Lee, M. Sherman, A. Ramji, S. Greenbloom, M. Elkashab, H. Pluta, N. Hilzenrat, R. Balshaw, C. Usaty, R. P. Myers

Journal:

Alimentary Pharmacology & Therapeutics

Année:

2012

Langue:

english

Fichier:

PDF, 312 KB

english, 2012

3

Extinction of R-S associations and performance on recall trials without informative feedback

Rose Greenbloom, Gregory A. Kimble

Journal:

Journal of Verbal Learning and Verbal Behavior

Année:

1965

Langue:

english

Fichier:

PDF, 558 KB

english, 1965

4

734 Peginterferon alpha-2a (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks in patients with HCV genotype 2 OR 3. Final results of the accelerate trial

M.L. Shiffman, S. Pappas, L. Nyberg, S. Greenbloom, A. Gibas, B. Bacons, J. Rasenack, F. Suter, M. Diago, A. Lin, A. Soman, S. Zeuzem

Journal:

Journal of Hepatology

Année:

2006

Langue:

english

Fichier:

PDF, 124 KB

english, 2006

5

O.160 16 or 24 weeks of peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin (RBV) (COPEGUS®) in patients with HCV genotype 2 or 3 and bridging fibrosis or cirrhosis: Results from a large, randomised multinational study (ACCELERATE)

S. Zeuzem, S. Pappas, L. Nyberg, S. Greenbloom, A. Gibas, B. Bacon, E. Godofsky, H. Harley, J. Bronowicki, A. Lin, A. Soman, M. Shiffman

Journal:

Journal of Clinical Virology

Année:

2006

Langue:

english

Fichier:

PDF, 143 KB

english, 2006

6

P.285 Differences in virus and host characteristics between patients with HCV genotype 2 or 3 participating in a large international study

S. Zeuzem, S. Pappas, L. Nyberg, S. Greenbloom, A. Gibas, B. Bacon, E. Godofsky, H. Harley, J. Bronowicki, A. Lin, G. Hooper, M. Shiffman

Journal:

Journal of Clinical Virology

Année:

2006

Langue:

english

Fichier:

PDF, 143 KB

english, 2006

7

Total enteral immunomodulatory nutrition (TEIN) treatment for severe active ulcerative colitis

Greenbloom, S.L., Wendland, B., Steinhart, A.H., McLeod, R.S., Cohen, Z., Greenberg, G.R.

Journal:

Gastroenterology

Année:

1995

Langue:

english

Fichier:

PDF, 156 KB

english, 1995

8

Outbreak of Trichinosis in Ontario Secondary to the Ingestion of Wild Boar Meat

Susan L. Greenbloom, Paul Martin-Smith, Sandy Isaacs, Barbara Marshall, Douglas C. Kittle, Kevin C. Kain and Jay S. Keystone

Journal:

Canadian Journal of Public Health / Revue Canadienne de Sante'e Publique

Année:

1997

Langue:

english

Fichier:

PDF, 1.87 MB

english, 1997

9

A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection

Muir, Andrew J., Arora, Sanjeev, Everson, Gregory, Flisiak, Robert, George, Jacob, Ghalib, Reem, Gordon, Stuart C., Gray, Todd, Greenbloom, Susan, Hassanein, Tarek, Hillson, Jan, Horga, Maria Arantxa,

Journal:

Journal of Hepatology

Année:

2014

Langue:

english

Fichier:

PDF, 1.43 MB

english, 2014

10

Quantification of HBsAg in nucleos(t)ide-naïve patients treated for chronic hepatitis B with entecavir with or without tenofovir in the BE-LOW study

Zoulim, Fabien, Carosi, Giampiero, Greenbloom, Susan, Mazur, Wlodzimierz, Nguyen, Tuan, Jeffers, Lennox, Brunetto, Maurizia, Yu, Song, Llamoso, Cyril

Journal:

Journal of Hepatology

Année:

2015

Langue:

english

Fichier:

PDF, 844 KB

english, 2015

11

1012 MALACHITE-I: Phase 3b Trial of Ombitasvir/Paritaprevir/R and Dasabuvir +/- Ribavirin or Telaprevir + Peginterferon/Ribavirin in Treatment-Naïve Adults With HCV Genotype 1

Conway, Brian, Janczewska, Ewa, Luo, Yan, Curescu, Manuela, Greenbloom, Susan, Streinu-Cercel, Adrian, Caruntu, Florin A., Ghesquiere, Wayne, Knysz, Brygida, Mazur, Wlodzimierz, Fuster, Francisco, Mot

Journal:

Gastroenterology

Année:

2015

Langue:

english

Fichier:

PDF, 1.63 MB

english, 2015

12

P0842 : Malachite-I: Phase 3B Trial of ombitasvir/paritaprevir/r and dasabuvir +/− ribavirin or telaprevir + peginterferon/ribavirin in treatment-naïve adults with HCV genotype 1

Conway, B., Janczewska, E., Luo, Y., Curescu, M., Greenbloom, S., Streinu-Cercel, A., Caruntu, F.A., Ghesquiere, W., Knysz, B., Mazur, W., Fuster, F., Motoc, A., Soza, A., Arama, V., Dalgard, O., Sull

Journal:

Journal of Hepatology

Année:

2015

Langue:

english

Fichier:

PDF, 50 KB

english, 2015

13

755 100% Svr4 and Favorable Safety of Abt-493 + Abt-530 Administered for 12 Weeks in Non-Cirrhotic Patients With Genotypes 4, 5, or 6 Infection (Surveyor-I)

Gane, Edward, Lalezari, Jacob, Asatryan, Armen, Greenbloom, Susan, Hassanein, Tarek I., Ng, Teresa, Liu, Ran, Lin, Chih-Wei, Kort, Jens, Mensa, Federico

Journal:

Gastroenterology

Année:

2016

Langue:

english

Fichier:

PDF, 701 KB

english, 2016

14

CONDITIONS OF CUE SELECTION IN THE ACQUISITION OF PAIRED-ASSOCIATE LISTS.

POSTMAN, LEO, GREENBLOOM, ROSE

Journal:

Journal of Experimental Psychology

Année:

1967

Langue:

english

Fichier:

PDF, 708 KB

english, 1967

15

Improvement in recall on unreinforced recall trials.

Greenbloom, Rose, Kimble, Gregory A.

Journal:

Journal of Experimental Psychology

Année:

1966

Langue:

english

Fichier:

PDF, 169 KB

english, 1966

16

100% SVR4 and Favorable Safety of ABT-493 + ABT-530 Administered for 12 Weeks in Non-Cirrhotic Patients with Genotypes 4, 5, or 6 Infection (Surveyor-I)

Gane, E., Lalezari, J., Asatryan, A., Greenbloom, S., Hassanein, T., Ng, T., Liu, R., Lin, C.-W., Kort, J., Mensa, F.

Journal:

Journal of Hepatology

Année:

2016

Langue:

english

Fichier:

PDF, 72 KB

english, 2016

17

Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir in Adults with Chronic Genotype 1-6 Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis

Gane, Edward, Poordad, Fred, Valdes, Joaquin M., Lin, Chih-Wei, Liu, Wei, Asatryan, Armen, Wang, Stanley, Stedman, Catherine A., Greenbloom, Susan, Nguyen, Tuan T., Elkhashab, Magdy, Wörns, Marcus-Ale

Journal:

Gastroenterology

Année:

2017

Langue:

english

Fichier:

PDF, 530 KB

english, 2017

18

Pharmacokinetics and safety of glecaprevir/pibrentasvir in adults with chronic genotype 1–6 hepatitis C virus infection and compensated cirrhosis: an integrated analysis

Gane, E., Poordad, F., Valdes, J., Lin, C.-W., Liu, W., Asatryan, A., Wang, S., Stedman, C., Greenbloom, S., Nguyen, T., Elkhashab, M., Wörns, M.-A., Tran, A., Mulkay, J.-P., Yu, Y., Porcalla, A., Men

Journal:

Journal of Hepatology

Année:

2017

Langue:

english

Fichier:

PDF, 83 KB

english, 2017

19

Dose response and safety of the daily, oral RIG-I agonist Inarigivir (SB 9200) in treatment naïve patients with chronic hepatitis B: results from the 25mg and 50mg cohorts in the ACHIEVE trial

Yuen, M.-F., Elkashab, M., Chen, C.-Y., Coffin, C., Fung, S., Greenbloom, S., Jang, J.W., Jeng, R.W.-J., Kim, D.J., Kim, Y.J., Kim, W., Lee, K.S., Lim, Y.-S., Ramji, A., Iyer, R., Macfarlane, C., Jack

Journal:

Journal of Hepatology

Année:

2018

Langue:

english

Fichier:

PDF, 134 KB

english, 2018

20

Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy

Cooper, Curtis, Shafran, Stephen, Greenbloom, Susan, Enns, Robert, Farley, John, Hilzenrat, Nir, Williams, Kurt, Elkashab, Magdy, Abadir, Nabil, Neuman, Manuela

Journal:

Canadian journal of gastroenterology & hepatology

Année:

2014

Fichier:

PDF, 2.46 MB

2014

21

Combination Ciprofloxacin and Metronidazole for Active Crohn’s Disease

Greenbloom, Susan L, Steinhart, A Hillary, Greenberg, Gordon R

Journal:

Canadian journal of gastroenterology

Année:

1998

Fichier:

PDF, 1.47 MB

1998

22

Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1–6 Hepatitis C Virus Infections and Compensated Liver Disease

Gane, Edward, Poordad, Fred, Zadeikis, Neddie, Valdes, Joaquin, Lin, Chih-Wei, Liu, Wei, Asatryan, Armen, Wang, Stanley, Stedman, Catherine, Greenbloom, Susan, Nguyen, Tuan, Elkhashab, Magdy, Wörns, M

Journal:

Clinical Infectious Diseases

Année:

2019

Langue:

english

Fichier:

PDF, 274 KB

english, 2019

23

GS-12-Ascending dose cohort study of inarigivir - A novel RIG I agonist in chronic HBV patients: Final results of the ACHIEVE trial

Yuen, Man-Fung, Chen, Chi-Yi, Liu, Chun-Jen, Jeng, RachelWen-Juei, Elkhashab, Magdy, Coffin, Carla, Kim, Won, Greenbloom, Susan, Ramji, Alnoor, Lim, Young-Suk, Kim, Yoon Jun, Fung, Scott, Kim, Dong Jo

Journal:

Journal of Hepatology

Année:

2019

Langue:

english

Fichier:

PDF, 122 KB

english, 2019

24

GS-12-Ascending dose cohort study of inarigivir - A novel RIG I agonist in chronic HBV patients: Final results of the ACHIEVE trial

Yuen, Man-Fung, Chen, Chi-Yi, Liu, Chun-Jen, Jeng, RachelWen-Juei, Elkhashab, Magdy, Coffin, Carla, Kim, Won, Greenbloom, Susan, Ramji, Alnoor, Lim, Young-Suk, Kim, Yoon Jun, Fung, Scott, Kim, Dong Jo

Journal:

Journal of Hepatology

Année:

2019

Fichier:

PDF, 122 KB

2019

25

Tu1850 DOSE ESCALATION OF UPADACITINIB IN CROHN'S DISEASE PATIENTS WITH INADEQUATE RESPONSE: DATA FROM THE RANDOMISED CELEST STUDY

Sandborn, William J., Panes, Julian, Peyrin-Biroulet, Laurent, Louis, Edouard, Greenbloom, Susan, Zhou, Wen, Zhou, Qian, Liu, Jianzhong, Lacerda, Ana P.

Journal:

Gastroenterology

Année:

2020

Fichier:

PDF, 497 KB

2020